Back to search

Article

A prospective national precision medicine trial comparing blood and tissue profiling in patients with Cancer of Unknown Primary (CUPCOMP)

2025-06-30

Abstract excerpt

<title>Abstract</title> <p>Background Cancer of Unknown Primary (CUP) is an aggressive malignancy with limited treatment options and poor patient outcomes. In most cases, the primary site remains elusive, limiting therapeutic options to non-specific chemotherapy. The CUPCOMP study assessed the feasibility of integrating a blood-based molecular profiling approach with a National Molecular Tumour Board (MTB) into...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
97209f2e-f851-5a63-8994-3c37266e0dcb
DOI
10.21203/rs.3.rs-6862916/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A prospective national precision medicine trial comparing blood and tissue profiling in patients with Cancer of Unknown Primary (CUPCOMP)DOI 10.21203/rs.3.rs-6862916/v1
Cancer of unknown primary (CUP) through the lens of precision oncology – a single institution perspectiveSemantic proximity
Comprehensive biomarker diagnostics of unfavorable cancer of unknown primary to identify patients eligible for precision medical therapies.Semantic proximity
Whole genome sequencing improves tissue-of-origin diagnosis and treatment options for cancer of unknown primarySemantic proximity
Comprehensive ctDNA Profiling Enables Tissue-of-Origin Prediction and Actionable Biomarker Detection in Cancer of Unknown PrimarySemantic proximity
Real-world data analysis of patients with cancer of unknown primarySemantic proximity
Utilizing Electronic Health Records (EHR) and Tumor Panel Sequencing to Demystify Prognosis of Cancer of Unknown Primary (CUP) patientsSemantic proximity
Cancers of Unknown Primary Origin: Real-World Clinical Outcomes and Genomic Analysis at the European Institute of Oncology.Semantic proximity
Significance of distinct liquid biopsy compartments in evaluating somatic mutations for targeted therapy selection in cancer of unknown primarySemantic proximity
Significance of Distinct Liquid Biopsy Compartments in Evaluating Somatic Mutations for Targeted Therapy Selection in Cancer of Unknown Primary.Semantic proximity
Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Origin: Retrospective Molecular Classification Considering the CUPISCO Study Design.Semantic proximity
Therapeutic Actionability of Circulating Cell-Free DNA Alterations in Carcinoma of Unknown PrimarySemantic proximity
Whole genome sequencing improves tissue of origin diagnosis and treatment options for cancer of unknown primarySemantic proximity
Select a neighboring publication to make it the new centre.